✦ LIBER ✦

Survival and Skeletal-related Events in Metastatic Castrate-resistant Prostate Cancer Patients Fit for Chemotherapy but Bisphosphonate-naive

✍ Scribed by Pell, R.; Harland, S.

Book ID: 122309126
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 44 KB
Volume: 26
Category: Article
ISSN: 1433-2981
DOI: 10.1016/j.clon.2013.11.018

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Updated Prognostic Model for Predicting

Updated Prognostic Model for Predicting Overall Survival in First-Line Chemotherapy for Patients With Metastatic Castration-Resistant Prostate Cancer

✍ Halabi, S.; Lin, C.-Y.; Kelly, W. K.; Fizazi, K. S.; Moul, J. W.; Kaplan, E. B.; 📂 Article 📅 2014 🏛 American Society of Clinical Oncology 🌐 English ⚖ 261 KB

Prognostic and predictive value of plasm

Prognostic and predictive value of plasma testosterone levels in patients receiving first-line chemotherapy for metastatic castrate-resistant prostate cancer

✍ de Liaño, A G; Reig, O; Mellado, B; Martin, C; Rull, E U; Maroto, J P 📂 Article 📅 2014 🏛 Nature Publishing Group 🌐 English ⚖ 746 KB

126 Long term safety and efficacy in a r

126 Long term safety and efficacy in a randomized multicenter international phase II study of tasquinimod in chemotherapy naïve patients with metastatic castrate-resistant prostate cancer

✍ A.J. Armstrong; J.R. Gingrich; M Häggman; W.M. Stadler; J.E. Damber; L. Belkoff; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 20 KB

684 RADIUM-223 CHLORIDE (ALPHARADIN) IMP

684 RADIUM-223 CHLORIDE (ALPHARADIN) IMPACT ON OVERALL SURVIVAL AND SKELETAL-RELATED EVENTS IN PATIENTS WITH CASTRATION-RESISTANT PROSTATE CANCER WITH BONE METASTASES A PHASE III RANDOMIZED TRIAL (ALSYMPCA)

✍ Sartor, Oliver; Heinrich, Daniel; Helle, Svein Inge; O'Sullivan, Joe M.; Chodack 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 50 KB

130 Overall survival benefit and impact

130 Overall survival benefit and impact on skeletal-related events for radium-223 chloride (Alpharadin) in the treatment of castration-resistant prostate cancer (CRPC) patients with bone metastases: A phase III randomized trial (ALSYMPCA)

✍ C. Parker; D. Heinrich; S.I. Helle; J.M O'Sullivan; S Fossä; A. Chodacki; T. Dem 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 107 KB

Effect of abiraterone acetate and predni

Effect of abiraterone acetate and prednisone compared with placebo and prednisone on pain control and skeletal-related events in patients with metastatic castration-resistant prostate cancer: exploratory analysis of data from the COU-AA-301 randomised trial

✍ Christopher J Logothetis; Ethan Basch; Arturo Molina; Karim Fizazi; Scott A Nort 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 342 KB